Cargando…

Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis

BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hua, Zhang, Yonggang, Feng, Shi, Li, Yina, Ye, Yingze, Jian, Zhihong, Xiong, Xiaoxing, Gu, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493663/
https://www.ncbi.nlm.nih.gov/pubmed/37088947
http://dx.doi.org/10.1111/cns.14232
_version_ 1785104527035203584
author Zhu, Hua
Zhang, Yonggang
Feng, Shi
Li, Yina
Ye, Yingze
Jian, Zhihong
Xiong, Xiaoxing
Gu, Lijuan
author_facet Zhu, Hua
Zhang, Yonggang
Feng, Shi
Li, Yina
Ye, Yingze
Jian, Zhihong
Xiong, Xiaoxing
Gu, Lijuan
author_sort Zhu, Hua
collection PubMed
description BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on the role of NLRP3 in ischemic stroke has developed rapidly worldwide. However, there is no bibliometric analysis of NLRP3 in ischemic stroke to date. AIM: Through bibliometric analysis, the aim of this study was to assess the current state of research on NLRP3 in the field of ischemic stroke research worldwide over the past 12 years and to identify important results, major research areas, and emerging trends. METHODS: Publications related to NLRP3 in ischemic stroke from January 1, 2011 to December 31, 2022 were obtained from the Web of Science Core Collection (WoSCC). We used HistCite, VOSviewer, CiteSpace, and Bibliometrix for bibliometric analysis and visualization. The Total Global Citation Score (TGCS) was employed to assess the impact of publications. RESULTS: We found that research of NLRP3 in ischemic stroke developed rapidly starting in 2011. 601 relevant studies have been published in 245 journals over the past 12 years. Journal of Neuroinflammation and International Immunopharmacology were the most productive journals and Journal of Neuroinflammation was the most cited journal. Additionally, Stroke and Journal of Cerebral Blood Flow & Metabolism were the most co‐cited journal. The most productive country was China (records = 430) and the most productive university was the Zhejiang University (records = 24). Arumugam TV (TGCS = 949) was the most cited author in this field. NLRP3 inflammasome activation, nf–κb, oxidative stress, and inflammation were the knowledge bases for the research in this field. CONCLUSION: This study is a scientometric study utilizing quantitative and qualitative methods to comprehensively review the publications on NLRP3 in ischemic stroke. This information provides a reference for scholars to further study NLRP3 in ischemic stroke.
format Online
Article
Text
id pubmed-10493663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104936632023-09-12 Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis Zhu, Hua Zhang, Yonggang Feng, Shi Li, Yina Ye, Yingze Jian, Zhihong Xiong, Xiaoxing Gu, Lijuan CNS Neurosci Ther Original Articles BACKGROUND: Ischemic stroke is a leading cause of permanent disability and death globally. The nucleotide‐biding oligomaerization domain (NOD)‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome is a multi‐protein complex that plays a role in ischemic stroke. Recently, research on the role of NLRP3 in ischemic stroke has developed rapidly worldwide. However, there is no bibliometric analysis of NLRP3 in ischemic stroke to date. AIM: Through bibliometric analysis, the aim of this study was to assess the current state of research on NLRP3 in the field of ischemic stroke research worldwide over the past 12 years and to identify important results, major research areas, and emerging trends. METHODS: Publications related to NLRP3 in ischemic stroke from January 1, 2011 to December 31, 2022 were obtained from the Web of Science Core Collection (WoSCC). We used HistCite, VOSviewer, CiteSpace, and Bibliometrix for bibliometric analysis and visualization. The Total Global Citation Score (TGCS) was employed to assess the impact of publications. RESULTS: We found that research of NLRP3 in ischemic stroke developed rapidly starting in 2011. 601 relevant studies have been published in 245 journals over the past 12 years. Journal of Neuroinflammation and International Immunopharmacology were the most productive journals and Journal of Neuroinflammation was the most cited journal. Additionally, Stroke and Journal of Cerebral Blood Flow & Metabolism were the most co‐cited journal. The most productive country was China (records = 430) and the most productive university was the Zhejiang University (records = 24). Arumugam TV (TGCS = 949) was the most cited author in this field. NLRP3 inflammasome activation, nf–κb, oxidative stress, and inflammation were the knowledge bases for the research in this field. CONCLUSION: This study is a scientometric study utilizing quantitative and qualitative methods to comprehensively review the publications on NLRP3 in ischemic stroke. This information provides a reference for scholars to further study NLRP3 in ischemic stroke. John Wiley and Sons Inc. 2023-04-23 /pmc/articles/PMC10493663/ /pubmed/37088947 http://dx.doi.org/10.1111/cns.14232 Text en © 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhu, Hua
Zhang, Yonggang
Feng, Shi
Li, Yina
Ye, Yingze
Jian, Zhihong
Xiong, Xiaoxing
Gu, Lijuan
Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title_full Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title_fullStr Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title_full_unstemmed Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title_short Trends in NLRP3 inflammasome research in ischemic stroke from 2011 to 2022: A bibliometric analysis
title_sort trends in nlrp3 inflammasome research in ischemic stroke from 2011 to 2022: a bibliometric analysis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493663/
https://www.ncbi.nlm.nih.gov/pubmed/37088947
http://dx.doi.org/10.1111/cns.14232
work_keys_str_mv AT zhuhua trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT zhangyonggang trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT fengshi trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT liyina trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT yeyingze trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT jianzhihong trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT xiongxiaoxing trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis
AT gulijuan trendsinnlrp3inflammasomeresearchinischemicstrokefrom2011to2022abibliometricanalysis